#Binding and Uptake of 125Iodine-Labelled, Oxidized Low Density Lipoprotein by Macrophages: Comparism of the Effects of α-Tocopherol, Probucol, Pyridoxal-5'-phosphate and Magnesium-pyridoxal-5'-phosphate-glutamate

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 52, Issue 1-2, 1997, Pages 97-104

  Selmer, Daniela ^a   Elstner, E F ^a   Senekowitsch Schmidtke, Reingard ^a   Schneider, W ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Steigerwald Arzneimittel GmbH   (Germany)

Author keywords

Low Density Lipoprotein; Macrophage

Indexed keywords

ALPHA TOCOPHEROL; IMMUNOGLOBULIN RECEPTOR; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MAGNESIUM; MEMBRANE PROTEIN; ORGANOMETALLIC COMPOUND; OXIDIZED LOW DENSITY LIPOPROTEIN; PROBUCOL; PYRIDOXAL 5 PHOSPHATE; RADIOACTIVE IODINE; SCARB1 PROTEIN, MOUSE; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR B;

ANIMAL; ARTICLE; BINDING COMPETITION; CELL CULTURE; COMPARATIVE STUDY; DRUG EFFECT; HUMAN; KINETICS; MACROPHAGE; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BINDING, COMPETITIVE; BIOLOGICAL TRANSPORT; HUMANS; IODINE RADIOISOTOPES; KINETICS; LIPOPROTEINS, LDL; MACROPHAGES; MAGNESIUM; MEMBRANE PROTEINS; ORGANOMETALLIC COMPOUNDS; PROBUCOL; PYRIDOXAL PHOSPHATE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LDL; RECEPTORS, LIPOPROTEIN; RECEPTORS, SCAVENGER; SCAVENGER RECEPTORS, CLASS B; TUMOR CELLS, CULTURED; VITAMIN E;

EID: 0030624363     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-1997-1-217     Document Type: Article

References (32)

1. Bradford M. A. (1976), A rapid and sensitive method for the quantitation of microgramm quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248.
2. Brown M. S. and Goldstein J. L. (1979), Receptor-mediated endocystis: insights from the lipoprotein receptor system. Proc. Natl. Acad. Sci. USA, Vol. 76, 3330-3337.
3. Brown M. S. and Goldstein J. L. (1985), Scavenger cell receptor shared. Nature. 316, 680-681.
4. Esterbauer H., Quenherberger I. and Jürgens G. (1988), Effect of peroxidative conditions on human plasma low-density lipoproteins. In: Eiconsanoids, Lipid Peroxidation and Cancer (Nigam et al. (eds.). Springer Verlag Berlin, Heidelberg, 203-213.
5. Esterbauer H., Dieber-Rotheneder M., Waeg G., Striegl G. and Jürgens G. (1990). Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem. Res. Toxicol. 3, 77-92.
6. Esterbauer H., Gebicki J., Puhl H. and Jürgens G. (1992a), The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad. Biol. & Med. 13, 341-390.
7. Esterbauer H., Puhl H., Dieber-Rotheneder M., Waeg G. and Rabl H. (1991a). Effect of antioxidants on oxidative modification of LDL. Ann. Med. 23, 573-581.
8. Esterbauer H., Puhl H., Waeg G., Krebs A. and Rotheneder M. (1992b), The role of vitamin E in lipoproteinoxidation. Vitamin E in Health and Disease. Marcel Dekker. New York. Basel. Hong-Kong.
9. Esterbauer H., Puhl H., Waeg G., Krebs A., Tatzber F. and Rabol H. (1993c). Vitamin E and Atherosclerosis An overview. Vitamin E - its usefulness in health and in curing disease. Jap. Sci. Soc. Press. Tokyo, 233-241.
10. Esterbauer H., Rotheneder M., Striegl G. and Waeg G. (1991b), Role of vitamin E in preventing the oxidation of LDL. Am J. Clin. Nutr. 53, 314-321.
11. Esterbauer H., Striegl G., Puhl H., Oberreither S., Rotheneder M. and Jürgens G. (1989), The role of vitamin E and Carotenoids in preventing oxidation of low density lipoproteins in Vitamin E. Biochemistry and Health Implications of the Annuals of the New York Academy of Science, December 26. Vol. 570.
12. Faulkner L., Aruoma O. I., Brickelt P. M. and Davies M. J. (1993), Effects of the synthetic antioxidant, probucol on the U937 monoblastoid cell line. Atherosclerosis 99, 1-3.
13. Havel R., Eder H. A. and Bragdon J. H. (1953), The distribution and chemical composition of ultra-centrifu-gally separated lipoproteins in human-serum. J. Clin. Invest., 34, 1345-1353.
14. Jessup W., Rankin S. M., De Whalley C. V., Hoult J. R. S., Scott J. and Leake D. S. (1990), α-Tocopherol consumption during low-density-lipoprotein oxidation. Biochem. J. 265, 399-405.
15. Jürgens G., Hoff H. F., Chrisolm G. M. and Esterbauer H. (1987), Modification of human serum low density lipoprotein by oxidation - characterization and pa-tho-physioloeical implications. Chem. Phvs. Lip. 45, 315-336.
16. Kögl Ch., Schneider W., Elstner E. F. (1994). The influence of magnesium-pyridoxal-5′-phosphate-glutamate in comparison with probucol. a-tocopherol and trolox on copper-induced oxidation of human low density lipoprotein in vitro. Biochem. Pharmacol., 47. No. 12, 2201-2206.
17. Kuzuya M. and Kuzuya F. (1993), Probucol as an antioxidant and antiatherogenic drug. Free Rad. Biol. & Med. 14, 76-77.
18. Kuzuya M., Yamada K., Hayashi T., Funaki C., Naito M., Asai K. and Kuzuya F. (1992). Role of lipoprotein-copper complex in copper catalyzed-peroxidation of low-densitv lipoprotein. Biochem. Biophvs. Acta 1123, 334-341.
19. Kuzuya M., Naito M., Funaki C., Hayashi T., Asai K. and Kuzuya F. (1993). Probucol prevents oxidative injury to endothelial cells. J. Lipid. Res. 32, 197-203.
20. Kuzuya M., Yamada K., Hayashi T., Funaki C., Naito M., Asai K. and Kuzuya F. (1991). Oxidation of low-density lipoprotein by copper and iron in phosphate buffer. Biochem. Biophys. Acta 1084, 198-201.
21. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. (1951), Protein measurement with the folin phenol reagent. J. Biol. Chem. 293:265-275.
22. Meyer B. U., Schneider W. and Elstner E. F. (1992). Peroxide-dependent amino acid oxidation and chemo-luminescence catalysed by magnesium-pyridoxalphos-phat-glutamat complex. Biochem. Pharmacol. 44, 505-508.
23. Nagano Y., Nakamura T., Matsuzawa Y., Cho M., Ueda Y. and Kita T. (1991), Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit - longterm antiatherogenic effect and effects on established plaques. Atherosclerosis 92, 131-140.
24. Parthasarathy S., Youn S. G., Witztum J. L., Pittman R. C. and Steinberg D. (1986), Probucol inhibits oxidative modification of low density lipoprotein. J. Clin. Invest. 77, 641-644.
25. Raschke W. C. (1978), Nature 276, 510-511.
26. Reid V. C. and Michinson M. J. (1993), Toxicity of oxidized LDL towards mous peritoneal macrophages in vitro. Atherosclerosis 98, 17-24.
27. Repke H., Liebmann C. (1987). Membranrezeptoren und ihre Effektorsysteme. VCHh Verlagsgesellschaft mbH, Weinheim. 1-101.
28. Selmer D. (1994): Bindung von Low Density Lipoprotein an Makrophagen unter dem Einfluβ von Magnesium-Pyridoxalphosphat-Glutamat und anderen Antioxidantien. PhD Thesis, TU München.
29. Sinn H. J., Schrenck H. H., Friedrich E. A., Via D. P., Desei H. A. (1988), Radioiodination of proteins using N-bromosuccinimide as oxidizing agent. Anal. Biochem. 170, 186-192.
30. Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C. and Witztum J. L. (1989), Beyond cholesterol-modifi-cations of low density lipoprotein that increase its atherogenicity. New Eng. J. Med. 320, 915-924.
31. Steinbrecher U. P., Lougheed M., Kwan W.-C. and Dirks M. (1989). Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatisation of apolipoprotein B by products of fattv acid peroxidation. J. Biol. Chem. 264, 15216-15223.
32. Steinbrecher U. P., Zhang H. and Lougheed M. (1990), Role of oxidatively modified LDL in atherosclerosis. Free Rad. Biol. & Med. 9, 155-168.